... Staging of small cell and non- smallcelllung cancer. University of Iowa Virtual Hos-pital; 1999. 6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-ment in patientswithlung cancer: ... Big Lung Trial in Non- Small- CellLung cancer. Journal of Clinical Oncology 2005, 30:7417-7427.12. Silvestri G, Pritchard R, Welch HG: Preferences for chemother-apy in patientswith advanced non- small ... stateutilities for metastatic breast cancer. Br J Cancer 2006,95(6):683-90.17. Cancer Research UK [http://www.cancerresearchuk.org]18. Cancer Help [http://www.cancerhelp.org.uk]19. Association for...
... factors associated with treatment-related pneumonitis (TRP) in patientswith non- small- celllungcancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy ... clinical and dosimetric factors associated with severe acute radiation pneumonitis in patientswith locally advanced non- smallcelllungcancer treated with concurrent chemotherapy and intensity-modulated ... (SARP) in patientswith locally advanced non- smallcelllungcancer (LANSCLC) treated with concurrent chemotherapy and intensity-modulated radiotherapy (IMRT).Methods: We analyzed 94 LANSCLC patients...
... Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.2. Non- smallCellLungCancer Collaborative Group: Chemotherapyin nonsmallcelllung cancer: a meta-analysis ... paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non- small- celllung cancer. The European Organi-zation for Research and Treatment of CancerLung Cancer Cooperative Group. J Clin Oncol ... JL:Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non- smallcelllung cancer: a lung cancer Galician group phase II study. Cancer Chemother Pharma-col 2007, 60:725-732.20....
... 70all patients stage IA patients treated with 48 Gy in 4 fractionsstage IB patients treated with 52 Gy in 4 fractionsall patients stage IA patients treated with 48 Gy in 4 fractionsstage IB patients ... 80% for all patients, and it was 81% for the stage IA patients treated with 48 Gy and 74% for the stage IB patients, with nosignificant diffe rence between them ( p =0.35).Twostage IA patients ... early-stage non- small- celllung cancer: clinical implications. Radiother Oncol2010, 94:1-11.27. Chen Y, Guo W, Lu Y, Zou B: Dose-individualized stereotactic bodyradiotherapy for T1-3N0 non- small cell...
... iotherapy, Oligometastases, Non- SmallCellLung Cancer Background Non- smallcelllungcancer (NSCLC) is the leadingcause of cancer mortality in the United States [1]. Patients with stage IV NSCLC ... Standard therapy for metastatic nonsmallcelllungcancer (NSCLC) includes palliative systemicchemotherapy and/or radiotherapy. Recent studies of patientswith limited metastases treated with curative-intentstereotactic ... AJCCstaging.Thesedatasupportthehypothesisthatselect patients with stage IV NSCLC have excellent outcomescomparable to unselected patientswith stage III diseasewhen treated aggressively with SBRT. Patients with initial limited...
... radiotherapy with surgery in patients with operable lung cancer. A randomized phase III trial of Radiosurgery Or Surgery for operable Early stage (stage 1A) non- smallcell Lung cancer (ROSEL, ClinicalTrials.gov ... body radiotherapy for stage I non- smallcelllung cancer. Radiother Oncol 2007, 85:429-434.39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-eral primary lung cancers: the Indiana ... planning of stereotacticradiotherapy. Therefore, an additional planning study wasperformed in 22 stage IA and 4 stage 1B non- small cell lungcancerpatients in order to develop and evaluate theplanning...
... To evaluate the performance of surface-based deformable image registration (DR) for adaptive radiotherapy of non- smallcelllungcancer (NSCLC).Methods: Based on 13 patientswith locally advanced ... OncologyOpen AccessResearchEvalution of surface-based deformable image registration for adaptive radiotherapy of non- smallcelllungcancer (NSCLC)Matthias Guckenberger*, Kurt Baier, Anne Richter, ... shrink-age was associated with changes of the spatial relationshipbetween the target and the parotid glands [8]. Similarfindings were made for non- small- celllung cancer (NSCLC), where a continuous...
... as lung cancer. It is more convenient for the patients and reduces health care costs.This study reports our results on patientswith medically inoperable, early stage, non- smallcell lung cancer ... 6(page number not for citation purposes)BackgroundThe use of accelerated hypofractionated radiation therapyis an attractive option forpatientswith early stage non- small celllungcancer (NSCLC) ... not for citation purposes)Radiation OncologyOpen AccessResearchAbsence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non- smallcelllung cancer Sergio...
... chemotherapy with cisplatin and vinorelbine in patients with locally advanced non- small- celllung cancer. Aphase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC). LungCancer ... radiotherapy forpatientswith unresecta-ble stage IIIA and B non- small- celllung cancer. J Clin Oncol2005, 23:3760-3767.46. El Sharouni SY, Kal HB, Battermann JJ: Accelerated regrowth of non- small- cell ... Inter-fraction interval in patientswith stage III non- small- cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy: final results in536 patients. Am J...
... Non- small- celllungcancer harbouring mutations in the EGFRkinase domain. Clin Transl Oncol 2010, 12:75-80.9. Gazdar AF: Activating and resistance mutations of EGFR in non- small- cell lung cancer: ... samples from 22 patients. IHC with the mAb against EGFR with del 19 was highly positive for the protein in all 17 patientswith a 15-bp (ELREA) deletion in exon 19, whereas in patients with other ... practice for screening EGFR mutations in NSCLC patients. Background Non- small- celllungcancer (NSCLC) is one of the mostfrequent human malignancies, constituting about 80% ofall lung tumors....
... clinicaloutcomes in patients treated with adjuvant chemotherapy aftercomplete resection of non- smallcelllung carcinoma. Cancer Res 2010,70:8288-98.19. Goldstraw P:The 7th Edition of TNM in Lung Cancer: ... Paclitaxel-carboplatin alone or with bevacizumab for non- small- celllung cancer. N Engl J Med 2006,355:2542-50.21. Besse B, Ropert S, Soria JC: Targeted therapies in lung cancer. Ann Oncol2007, 18(Suppl ... marker expression in tumor cells versus stromal cells in non smallcelllung cancer. Clin Cancer Res 2007, 13:6649-57.24. World Health Organization: Histological Typing of Lung and PleuralTumours....
... non- smallcelllungcancer cell lines. Mol Cancer Res. 2006; 4(8): 521-8. 102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to classify non- small- celllungcancerpatientsfor ... in non- small cell lungcancer Is correlated with survival. Clin Cancer Res. 2001; 7(7): 1850-5. 93. Cappuzzo F, Gregorc V, Rossi E, et al. Gefitinib in pretreated non- small- celllungcancer ... death world-wide (1). Lungcancer is generally classified into two histological types, smallcelllungcancer (SCLC) and non smallcelllungcancer (NSCLC). NSCLC accounts for approximately 85%...